Clinical trial
Assessment of the Effectiveness of Updated Educational Materials on Prescribers' Knowledge and Behavior With Respect to Risks Associated With INSTANYL® Off-Label Use
NCT04938440 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Effectiveness of Updated Educational Materials on Prescribers' Knowledge and Behavior With Respect to Risks Associated With INSTANYL® Off-Label Use
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 18, 2022
- Completion date
- February 6, 2023
- Enrollment
- 536 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.